ABHI 2017: Hopes, Fears And Opportunities On UK Medtech Agenda

Securing market access at a time of an unprecedented budget squeeze, driving forward with medtech and digital innovation plans and maintaining barrier-free access to the EU market: these are the uppermost thoughts on the minds of UK medtech bosses. It's hard, but it's not mission impossible, industry and government leaders said at the ABHI's 2017 UK Market Conference.

If there is one thing the UK medtech industry needs, it's a single NHS "front door" to innovators, according to ABHI chair Phil Kennedy. Or better engagement with the NHS and more individual conversations with industry, with NHS Improvement (NHSI) in the role of enabler, according to ABHI chief executive Peter Ellingworth.

Or the Sustainability and Transformation Partnerships (STPs) and Trusts knowing just what technological innovations are out there and available to them, according to one STP lead,

These may be different shades of the same answer, but the ever-present truth for UK medtech is that developing innovation is not the problem, rather its adoption and putting it into service

More from United Kingdom

More from Europe